Lakefront BiotherapeuticsvsEli Lilly and Company

LKFT and LLY stock compared: price, dividend, valuation and results, from SEC filings.

LKFT

Lakefront Biotherapeutics

$33.31

Value $2.2B

-0.24%
LKFT's page

LLY

Eli Lilly and Company

$1,347.11

Value $1.27T

-0.30%
LLY's page

Lakefront Biotherapeutics (LKFT) has a market value of $2.2B and Eli Lilly and Company (LLY) $1.27T. Over the last year, with dividends, LKFT moved +9.2% and LLY +29.1%. The P/E is 5.8 for LKFT and 46.1 for LLY. Dividend yield: LKFT none, LLY 0.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LKFT$2.2B

    LLY$1.27T

    LLY is 579 times LKFT

  • Revenue, 12 months

    LKFT$1.3B

    LLY$86.5B

    LLY is 66 times LKFT

  • Net income, 12 months

    LKFT$377M

    LLY$27.6B

    LLY is 73 times LKFT

  • Operating margin

    LKFT26.5%

    LLY–

  • ROIC

    LKFT7.2%

    LLY35.5%

    28.3 points apart

  • P/E

    LKFT5.8

    LLY46.1

    LLY is 7.9 times LKFT

  • Dividend yield

    LKFT0.0%

    LLY0.5%

    0.5 points apart

  • 5-year return

    LKFT-35.3%

    LLY+439.5%

    474.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LKFT-35.3%

LLY+439.5%

20040060020222023202420252026
Returns by period
PeriodLKFTWith dividendsLLYWith dividends
1 year since November 19, 2025+9.2%Price +9.2%+29.1%Price +28.3%
3 years since November 20, 2023-10.9%-3.8% a yearPrice -10.9%+130.0%+32.0% a yearPrice +125.4%
5 years since November 19, 2021-35.3%-8.3% a yearPrice -35.3%+439.5%+40.1% a yearPrice +416.7%
10 years since November 22, 2016-42.5%-5.4% a yearPrice -42.5%+1,962.1%+35.3% a yearPrice +1,672.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LKFTLakefront BiotherapeuticsLLYEli Lilly and Company

Valuation

LKFTLLY
Valuation
Price$33.31$1,347.11
Market value$2.2B$1.27T
Enterprise value (EV)$2.1B$1.32T
P/E5.846.1
P/E, 5-year median11.549.9
P/B0.631.6
EV/EBIT6.137.8
Free cash flow yield–1.6%

Results and growth

LKFTLLY
Results and growth
Revenue, 12 months$1.3B$86.5B
Net income, 12 months$377M$27.6B
Free cash flow, 12 months-$318M$19.7B
Earnings per share, 12 months$5.72$30.81
Revenue growth, year on year303.5%44.7%
Revenue growth a year, past+18.4%over 5 years+21.6%over 5 years
EPS growth a year, past–+27.6%over 5 years

Margins and returns on capital

LKFTLLY
Margins and returns on capital
Gross margin97.3%83.6%
Operating margin26.5%–
Net margin28.8%31.9%
ROIC7.2%35.5%
ROE9.9%88.6%

Balance sheet

LKFTLLY
Balance sheet
Cash$103M$4.9B
Total debt$8.1M$49.5B
Net debt / EBITDA–1.2
Interest cover–38.9×

Dividends and buybacks

LKFTLLY
Dividends and buybacks
Dividend yield–0.5%
Dividend per share, 12 months–$6.34
Dividend growth a year, past–+15.2%over 5 years
Buyback yield–0.3%
Shareholder yield–0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LKFT or LLY

Didn't find what you were looking for?

Ask us
Which is bigger, Lakefront Biotherapeutics or Eli Lilly and Company?

By market value, Eli Lilly and Company ($1.27T) is about 578.9 times Lakefront Biotherapeutics ($2.2B), at today's prices.

How did LKFT and LLY stock do over the last 10 years?

Since November 22, 2016, LKFT's price moved -42.5% and LLY's +1,672.7%. With dividends: LKFT -42.5% (-5.4% a year), LLY +1,962.1% (+35.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, LKFT or LLY?

The dividend yield at today's price is none for Lakefront Biotherapeutics and 0.47% for Eli Lilly and Company. Over the last twelve months they paid – and $6.34 per share.

What is the P/E of LKFT and LLY?

At today's price, the P/E is 5.8 for LKFT and 46.1 for LLY. The median of the last five years was 11.5 and 49.9, which shows where each stands against its own past.

Which has the higher profit margins, Lakefront Biotherapeutics or Eli Lilly and Company?

Over the last twelve months, the net margin was 28.8% for Lakefront Biotherapeutics and 31.9% for Eli Lilly and Company, and the operating margin 26.5% and –. Revenue was $1.3B and $86.5B.

Which is the better investment, Lakefront Biotherapeutics or Eli Lilly and Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.